Verdine Gregory L.
SEC Form 4 insider trading activity
Verdine Gregory L. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 10, 2025.
On the most recent filing, Verdine Gregory L. is listed as Director at Wave Life Sciences Ltd. Inside the rolling window, Verdine Gregory L. reported no open-market purchases and 1 open-market sale totaling $269K in WVE.
Companies traded
Other insiders at WVE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$269K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Verdine Gregory L. made?
Verdine Gregory L. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2025.
Which companies does Verdine Gregory L. trade?
Verdine Gregory L. has filed SEC Form 4 disclosures for 1 company, including WVE.
When was Verdine Gregory L.'s most recent SEC Form 4 filing?
Verdine Gregory L.'s most recent SEC Form 4 filing on Tracefour is dated Dec 10, 2025.
What is Verdine Gregory L.'s total buy and sell value in the current window?
Inside the rolling retention window, Verdine Gregory L. bought $0 and sold $269K based on SEC Form 4 filings.
What was Verdine Gregory L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 WVE shares on 2025-12-08, worth $269K, per SEC Form 4 filings.